GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $771,000 | -3.1% | 20,959 | -0.9% | 0.02% | -16.7% |
| Q3 2020 | $796,000 | -12.7% | 21,145 | -5.4% | 0.02% | -17.2% |
| Q2 2020 | $912,000 | +7.7% | 22,352 | 0.0% | 0.03% | -9.4% |
| Q1 2020 | $847,000 | -19.1% | 22,352 | +0.3% | 0.03% | +23.1% |
| Q4 2019 | $1,047,000 | +7.8% | 22,290 | -2.0% | 0.03% | -3.7% |
| Q3 2019 | $971,000 | -74.1% | 22,739 | -75.7% | 0.03% | -73.8% |
| Q2 2019 | $3,751,000 | -1.1% | 93,716 | +3.3% | 0.10% | -3.7% |
| Q1 2019 | $3,792,000 | +357.4% | 90,734 | +318.3% | 0.11% | +296.3% |
| Q4 2018 | $829,000 | +9.8% | 21,691 | +15.4% | 0.03% | +28.6% |
| Q3 2018 | $755,000 | -2.8% | 18,803 | -2.5% | 0.02% | -4.5% |
| Q2 2018 | $777,000 | +3.1% | 19,292 | 0.0% | 0.02% | +4.8% |
| Q1 2018 | $754,000 | +12.0% | 19,292 | +1.8% | 0.02% | +16.7% |
| Q4 2017 | $673,000 | -15.3% | 18,958 | -3.2% | 0.02% | -18.2% |
| Q3 2017 | $795,000 | -15.2% | 19,586 | -9.9% | 0.02% | -18.5% |
| Q2 2017 | $938,000 | +3.1% | 21,749 | +0.7% | 0.03% | +3.8% |
| Q1 2017 | $910,000 | +11.9% | 21,602 | +2.3% | 0.03% | +8.3% |
| Q4 2016 | $813,000 | +1.9% | 21,112 | +14.1% | 0.02% | 0.0% |
| Q3 2016 | $798,000 | -0.5% | 18,507 | 0.0% | 0.02% | -7.7% |
| Q2 2016 | $802,000 | +2.0% | 18,507 | -4.5% | 0.03% | +13.0% |
| Q1 2016 | $786,000 | -6.1% | 19,389 | -6.5% | 0.02% | -8.0% |
| Q4 2015 | $837,000 | -10.6% | 20,737 | -14.9% | 0.02% | -13.8% |
| Q3 2015 | $936,000 | -1.8% | 24,360 | +6.5% | 0.03% | +11.5% |
| Q2 2015 | $953,000 | -10.3% | 22,867 | -0.8% | 0.03% | -13.3% |
| Q1 2015 | $1,063,000 | +12.0% | 23,047 | +3.8% | 0.03% | +15.4% |
| Q4 2014 | $949,000 | -10.0% | 22,197 | -3.3% | 0.03% | -13.3% |
| Q3 2014 | $1,055,000 | -6.2% | 22,954 | +9.1% | 0.03% | -6.2% |
| Q2 2014 | $1,125,000 | +1.7% | 21,035 | +1.6% | 0.03% | 0.0% |
| Q1 2014 | $1,106,000 | +5.1% | 20,697 | +5.0% | 0.03% | +3.2% |
| Q4 2013 | $1,052,000 | +62.1% | 19,704 | +52.4% | 0.03% | +55.0% |
| Q3 2013 | $649,000 | +5.9% | 12,930 | +5.5% | 0.02% | 0.0% |
| Q2 2013 | $613,000 | – | 12,260 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |